An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection. Alongside growing evidence of the domestic spread of such resistant strains in Europe over the last two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Centre for Disease Prevention and Control (ECDC) today…
Source: European Centre for Disease Prevention and Control (ECDC)
European Centre for Disease Prevention and Control (ECDC)
- Strengthening public health emergency operations centres in Europe through exchange of good practices
- Record-high West Nile virus infections reported amid spread to new parts of Europe
- Ebola disease outbreak in the Democratic Republic of the Congo
- ECDC closely monitoring situation following case of pneumonia of unknown origin in Russia
- Chikungunya virus disease worldwide overview
- EU-led assessment to Albania will strengthen cross-sector response to antimicrobial resistance
- Risk to general population remains very low following fourth imported Ebola case in Europe
- New hepatitis surveillance report shows strengthened public health cooperation with EU candidate countries
- MERS-CoV worldwide overview
- Cholera worldwide overview
